Lipemic plasma: A renaissance

Transfusion

Volumn 51, Issue 6, 2011, Pages 1136-1139

  Vassallo, Ralph R ^a   Stearns, Frank M ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

APHERESIS; BLOOD DONOR; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; POSTPRANDIAL STATE; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDITY;

ADULT; BLOOD DONORS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PLASMA; RISK FACTORS;

EID: 79958863473     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03142.x     Document Type: Review

References (19)

1. Peffer K, de Kort WL, Slot E, Doggen CJ,. Turbid plasma donations in whole blood donors. Fat chance? Transfusion 2011; 51: 1179-87.
2. Albrink MJ, Man EB, Peters JP,. The relation of neutral fat to lactescence of serum. J Clin Invest 1955; 34: 147-57.
3. Goldberg IJ,. Hypertriglyceridemia: impact and treatment. Endocrinol Metab Clin North Am 2009; 38: 137-49.
4. Kroll MH,. Evaluating interference caused by lipemia. Clin Chem 2004; 50: 1968-9. (Pubitemid 39425829)
5. National Cholesterol Education (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
6. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH,. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Int Med 2009; 169: 572-8.
7. Lloret Linares C, Pelletier AL, Czernichow S, Vergnaud AC, Bonnefont-Rousselot D, Levy P, Ruszniewski P, Bruckert E,. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008; 37: 13-22.
8. Cohn JS,. Postprandial lipemia and remnant lipoproteins. Clin Lab Med 2006; 26: 773-86. (Pubitemid 44716508)
9. Williams CM, Moore F, Morgan L, Wright J,. Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. Br J Nutr 1992; 68: 655-66. (Pubitemid 23027126)
10. Glick MR, Ryder KW, Glick SJ, Woods JR,. Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients. Clin Chem 1989; 35: 837-9. (Pubitemid 19162085)
11. Simundic AM, Nikolac N, Ivankovic V, Ferenic-Ruzic D, Magdic B, Kvaternik M, Topic E,. Comparison of visual versus automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? Clin Chem Lab Med 2009; 47: 1361-5.
12. Twomey PJ, Don-Wauchope AC, McCullough D,. Unreliability of triglyceride measurement to predict turbidity induced interference. J Clin Pathol 2003; 56: 861-2. (Pubitemid 37386576)
13. Stearns FM, Stramer SL, Alvarez AW,. Verification of visual lipemic sample suitability by quantitative triglyceride testing. Transfusion 2005; 45 (3S): SP199.
14. Lopez-Miranda J, Williams C, Lairon D,. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007; 98: 458-73. (Pubitemid 47272862)
15. Sanders TA,. Dietary fat and postprandial lipids. Curr Atheroscler Rep 2003; 5: 445-51. (Pubitemid 38906741)
16. Lairon D,. Macronutrient intake and modulation on chylomicron production and clearance. Atheroscler Suppl 2008; 9: 45-8.
17. Lopez-Miranda J, Perez-Martinez P, Marin C, Moreno JA, Gomez P, Perez-Jimenez F,. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr Opin Lipidol 2006; 17: 132-8.
18. Rosenson RS,. Approach to the patient with hypertriglyceridemia. In:, Freeman MW, editor. UpToDate. Waltham (MA): UpToDate; 2011.
19. Zock PL, Katan MB, Merkus MP, van Dusseldorp M, Harryvan JL,. Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet 1990; 335: 1235-7. (Pubitemid 20181779)